Shopping Cart
Remove All
Your shopping cart is currently empty
Quinaprilat is an orally active ACE inhibitor, the active metabolite of quinapril, and a substrate for OAT3. It blocks the conversion of angiotensin I to angiotensin II, exhibiting antihypertensive activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $71 | - | In Stock | |
| 5 mg | Preferential | - | In Stock |
| Description | Quinaprilat is an orally active ACE inhibitor, the active metabolite of quinapril, and a substrate for OAT3. It blocks the conversion of angiotensin I to angiotensin II, exhibiting antihypertensive activity. |
| In vitro | Quinaprilat (5μM) promotes its own active renal secretion by mediating the interaction with hOAT3, increasing the uptake by HEK293 cells to 25 times the original level, with a Km value of 13.4μM for its binding [1]. Quinaprilat (100 nM, 20 minutes) can activate the B1 receptor, thereby inhibiting PKC activity and leading to NO release from HLMVE cells [2]. |
| In vivo | Quinaprilat (3 mg/kg, once daily for 6 days) was administered via oral gavage and demonstrated certain antihypertensive effects in male SHR rats when used in combination with other medications [1]. |
| Synonyms | CI-928, CI928, CI 928 |
| Molecular Weight | 410.46 |
| Formula | C23H26N2O5 |
| Cas No. | 82768-85-2 |
| Smiles | C([C@@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C)(=O)N2[C@H](C(O)=O)CC=3C(C2)=CC=CC3 |
| Relative Density. | 1.289 g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Soluble, Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.